Azar said that any approach to bring down drug prices that does not tackle pharmacy benefit manager rebates “will not deliver the results.”
As they pay more for healthcare and expect technology to enable their interactions with service providers, consumers are now more engaged.
Idaho’s governor has signed off on a scaled-back Medicaid expansion plan, making it the second state to retool a voter-mandated expansion.
Executives insist the pharmacy benefit management space is a competitive one, but industry watchers aren't so sure.
The Trump administration will appeal a judge’s decision to block Medicaid work requirements in two states.
The chairs of three House committees want answers from the Trump administration on its new approach in the court battle over the legality of the ACA.
Healthcare and health IT groups are supporting recently proposed legislation aimed at reforming a patient privacy regulation by aligning it with HIPAA.
Hospital leaders were treated to opposing arguments from the nation's top congressional leaders headed to the AHA's annual meeting Tuesday.
Pharmacy benefit managers warn that eliminating drug rebates puts little pressure on pharmaceutical companies to drive down costs.
The Trump administration is interested in the concept of creating post-acute care bundles, the head of the CMMI told an audience on Monday.